Pharmafile Logo
Pharmafocus logo
Advanced Search

value-based pricing

Showing 8 posts of 23 posts found.

Valuing medicines and NHS reform – the ABPI view

December 10, 2010
Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing

For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …

Feature

UK pharma faces rising costs from value-based pricing

December 3, 2010
Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing

The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …

News

Change is needed, concedes NICE chief, but defends record

November 30, 2010
Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing

The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …

Feature
ABPI

Value-based pricing no ‘magic bullet’ – ABPI

November 16, 2010
Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing

UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …

News

NICE ‘surprised’ at downgrading of its role

November 5, 2010
Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing

NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …

News

£600m confirmed for three year Cancer Drugs Fund

October 27, 2010
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NICE, cancer drugs, value-based pricing

The NHS will get the extra money it was promised to improve patient access to cancer medicines not backed by …

News

Minister confirms NICE will be sidelined in drug evaluation

October 26, 2010
Sales and Marketing Andrew Lansley, Lord Howe, NICE, PPRS, medicines pricing, value-based pricing

A health minister has confirmed NICE will be “moved” from its current central role in health technology assessment to make …

News

PM hints pharma could avoid ‘value-based’ pricing

March 9, 2007
Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing

 Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026